Healthcare Ebitda from 2010 to 2024

HTIA Stock  USD 15.70  0.01  0.06%   
Healthcare Trust's EBITDA is increasing over the years with slightly volatile fluctuation. EBITDA is expected to dwindle to about 78.9 M. From 2010 to 2024 Healthcare Trust EBITDA quarterly data regression line had arithmetic mean of  58,054,887 and significance of  0. View All Fundamentals
 
EBITDA  
First Reported
2013-03-31
Previous Quarter
-115.8 M
Current Value
-2 M
Quarterly Volatility
22 M
 
Yuan Drop
 
Covid
Check Healthcare Trust financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Healthcare Trust's main balance sheet or income statement drivers, such as Depreciation And Amortization of 162 M, Interest Expense of 38.7 M or Selling General Administrative of 15.4 M, as well as many indicators such as Price To Sales Ratio of 1.06, Dividend Yield of 0.0338 or PTB Ratio of 0.54. Healthcare financial statements analysis is a perfect complement when working with Healthcare Trust Valuation or Volatility modules.
  
Check out the analysis of Healthcare Trust Correlation against competitors.

Latest Healthcare Trust's Ebitda Growth Pattern

Below is the plot of the Ebitda of Healthcare Trust PR over the last few years. It is Healthcare Trust's EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Healthcare Trust's overall financial position and show how it may be relating to other accounts over time.
Ebitda10 Years Trend
Slightly volatile
   Ebitda   
       Timeline  

Healthcare Ebitda Regression Statistics

Arithmetic Mean58,054,887
Coefficient Of Variation74.51
Mean Deviation38,704,991
Median79,789,000
Standard Deviation43,256,296
Sample Variance1871.1T
Range104.8M
R-Value0.76
Mean Square Error851.8T
R-Squared0.58
Significance0
Slope7,349,036
Total Sum of Squares26195.5T

Healthcare Ebitda History

202478.9 M
202381.1 M
202279.8 M
202182.6 M
202092.6 M
201996.8 M
2018101.3 M

About Healthcare Trust Financial Statements

Healthcare Trust stakeholders use historical fundamental indicators, such as Healthcare Trust's Ebitda, to determine how well the company is positioned to perform in the future. Although Healthcare Trust investors may analyze each financial statement separately, they are all interrelated. For example, changes in Healthcare Trust's assets and liabilities are reflected in the revenues and expenses on Healthcare Trust's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Healthcare Trust PR. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
EBITDA81.1 M78.9 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Healthcare Trust offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Healthcare Trust's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Healthcare Trust Pr Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Healthcare Trust Pr Stock:
Check out the analysis of Healthcare Trust Correlation against competitors.
You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Is Real Estate Management & Development space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Healthcare Trust. If investors know Healthcare will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Healthcare Trust listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.07)
Revenue Per Share
12.357
Quarterly Revenue Growth
0.032
Return On Assets
(0.0004)
Return On Equity
(0.20)
The market value of Healthcare Trust is measured differently than its book value, which is the value of Healthcare that is recorded on the company's balance sheet. Investors also form their own opinion of Healthcare Trust's value that differs from its market value or its book value, called intrinsic value, which is Healthcare Trust's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Healthcare Trust's market value can be influenced by many factors that don't directly affect Healthcare Trust's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Healthcare Trust's value and its price as these two are different measures arrived at by different means. Investors typically determine if Healthcare Trust is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Healthcare Trust's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.